530 related articles for article (PubMed ID: 29981923)
21. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.
McGill MR; Jaeschke H
Expert Rev Mol Diagn; 2018 Sep; 18(9):797-807. PubMed ID: 30080986
[TBL] [Abstract][Full Text] [Related]
23. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
24. Development of a cell-based assay system considering drug metabolism and immune- and inflammatory-related factors for the risk assessment of drug-induced liver injury.
Yano A; Oda S; Fukami T; Nakajima M; Yokoi T
Toxicol Lett; 2014 Jul; 228(1):13-24. PubMed ID: 24747151
[TBL] [Abstract][Full Text] [Related]
25. Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints.
Liu X; Zheng D; Zhong Y; Xia Z; Luo H; Weng Z
Biomed Res Int; 2020; 2020():4795140. PubMed ID: 32509859
[TBL] [Abstract][Full Text] [Related]
26. Gene Expression Data Based Deep Learning Model for Accurate Prediction of Drug-Induced Liver Injury in Advance.
Feng C; Chen H; Yuan X; Sun M; Chu K; Liu H; Rui M
J Chem Inf Model; 2019 Jul; 59(7):3240-3250. PubMed ID: 31188585
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
[TBL] [Abstract][Full Text] [Related]
28. Systems toxicology: modelling biomarkers of glutathione homeostasis and paracetamol metabolism.
Stahl SH; Yates JW; Nicholls AW; Kenna JG; Coen M; Ortega F; Nicholson JK; Wilson ID
Drug Discov Today Technol; 2015 Aug; 15():9-14. PubMed ID: 26464084
[TBL] [Abstract][Full Text] [Related]
29. Drug-Induced Liver Injury: Highlights of the Recent Literature.
Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
[TBL] [Abstract][Full Text] [Related]
30. In silico models for drug-induced liver injury--current status.
Przybylak KR; Cronin MT
Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):201-17. PubMed ID: 22248266
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
32. In silico Prediction of Drug Induced Liver Toxicity Using Substructure Pattern Recognition Method.
Zhang C; Cheng F; Li W; Liu G; Lee PW; Tang Y
Mol Inform; 2016 Apr; 35(3-4):136-44. PubMed ID: 27491923
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
[TBL] [Abstract][Full Text] [Related]
34. In Silico Prediction of Drug-Induced Liver Injury Based on Ensemble Classifier Method.
Wang Y; Xiao Q; Chen P; Wang B
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443562
[TBL] [Abstract][Full Text] [Related]
35. Predictability of drug-induced liver injury by machine learning.
Chierici M; Francescatto M; Bussola N; Jurman G; Furlanello C
Biol Direct; 2020 Feb; 15(1):3. PubMed ID: 32054490
[TBL] [Abstract][Full Text] [Related]
36. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced liver injury and drug development: industry perspective.
Regev A
Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced liver injury.
Holt M; Ju C
Handb Exp Pharmacol; 2010; (196):3-27. PubMed ID: 20020257
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.
Umbaugh DS; Jaeschke H
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):363-375. PubMed ID: 33242385
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
